Navigation Links
Cancer health disparities research highlighted at AACR 101st Annual Meeting 2010
Date:4/18/2010

from breast cancer in the Inland Empire is consistent with later detection of this screening-detectable cancer among these women," Tadi-Uppala said.

Non-Hispanic white women had a higher-risk of death from breast cancer than the statewide average. Results also showed the following:

  • approximately 11.6 percent of homes had an income below poverty level;
  • 24 percent of participants (mostly black and Latina) aged 16 to 64 years were uninsured;
  • approximately 60 percent were not educated about breast health;
  • 71 percent over 40 years of age did not have a mammogram in the last year; and
  • nearly 80 percent were willing to participate in breast cancer clinical trials, but were not given opportunities to do so.

Tadi-Uppala and colleagues are currently working to educate minority women about the importance of participating in clinical trials, to recruit minority women into clinical trials, and to address lifestyle factors that affect breast cancer among minority women in the Inland Empire.

"We hope funding will be available to schools of public health such as ours that engage in community-based participatory research to reduce breast cancer incidence, morbidity and mortality among minority women who our research demonstrates currently experience an unequal burden of cancer," she said.

990. Fundamental causes of colorectal cancer outcomes

Socioeconomic status plays a role in colorectal cancer mortality rates by hindering health care interventions and/or restricting patient access to care, according to results of a retrospective cohort study.

"Those living in low socioeconomic status counties have yet to benefit from advances made in preventing colorectal cancer deaths more than 30 years ago, whereas those living in high socioeconomic status counties have seen a 33 percent to 50 percent reduction in mortality," said Andrew C. Wang, M.P.H., research assistant and student
'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related biology news :

1. Advocates and researchers educate community about cancer in game show format
2. UC to test targeted treatment for prostate cancer
3. TGen-Asuragen partner to advance pancreatic cancer research
4. Genetic signatures provide new direction in liver cancer
5. Texas Childrens Cancer Center first in Texas to magnetically lengthen nine-year-olds leg as she grows
6. $2.3 million in NIH funding for promising cancer research at Cincinnati Childrens
7. 2nd European Lung Cancer Conference
8. Slobbery kisses from mans best friend aid cancer research
9. McGill plays important role in new global cancer-research network
10. Research discovery may lead to advances in heart disease and cancer treatment
11. Scientists find new genes for cancer, other diseases in plants, yeast and worms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2015)... and TELTOW, Germany , August ... (SMI), a world leader in Eye Tracking Technology ... of its OEM Eye Tracking Platform for integration into ... Platform contains reference designs for seamless integration of eye ... virtual reality HMDs and augmented reality smart glasses. Omnivision,s ...
(Date:8/6/2015)... Calif. , Aug. 6, 2015  Today, ... will visit Crossmatch ™ to learn firsthand ... and protect data. Crossmatch is a world leader ... technologies and expertise are helping federal agencies and ... and security.   "The vast majority ...
(Date:8/6/2015)... Aug. 6, 2015 Synaptics Inc. (NASDAQ: ... interface solutions, today announced collaboration with Microsoft on ... 10. Microsoft leveraged Synaptics, deep expertise in human ... Through stringent testing, Synaptics, advanced ... with Microsoft,s Precision TouchPad (PTP) specification empowering OEMs ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Rep. Honda to Visit Crossmatch in Redwood City 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... and instead reduce fossil-fuel use for the sake of the ... the University of Washington and one from the University of ... issue of the journal Nature (Jan. 26) that ... the environment as a reason to curb the use of ...
... MIT researchers have discovered that certain photosynthetic ocean ... viruses are really con artists carrying genetic material taken ... host into using its own machinery to activate the ... relationship. The con occurs when a grifter ...
... officers can now register online to the 2012 General ... brings together over 10,000 scientists from all over the ... and space sciences. EGU,s General Assembly is an ... recent developments in topics as diverse as shale gas ...
Cached Biology News:Commentary in Nature: Can economy bear what oil prices have in store? 2Commentary in Nature: Can economy bear what oil prices have in store? 3Viruses con bacteria into working for them 2Viruses con bacteria into working for them 3European Geosciences Union General Assembly, April 22-27, 2012, Vienna, Austria 2
(Date:9/2/2015)... 2015 Research ... the addition of Jain PharmaBiotech,s new report ... to their offering. The ... fluorescence in situ hybridization (FISH), comparative genomic ... includes application of nanobiotechnology, microarrays, real-time polymerase ...
(Date:9/2/2015)... , Sept. 2, 2015 Australian prostate cancer ... prestigious Australian science prize recognising ,outstanding, science that uses ... to globally launch a novel prostate cancer diagnostic test ... high level consortium taking out the peer-reviewed Australian Museum ... Research. This prize is awarded for ...
(Date:9/2/2015)... , September 2, 2015 BiondVax ... of the National Institute of Allergy and Infectious Diseases (NIAID), ... the Department of Health and Human Services (HHS), to launch ... the United States in the 2015-16 timeframe. ... vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which would ...
(Date:9/2/2015)... ... September 02, 2015 , ... Temarry Recycling's new $100,000 ... to energy process and continue to contribute to the sustainability of our natural ... to Energy process has been operating at their Mexico facility, Recicladora Temarry, for ...
Breaking Biology Technology:Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Temarry Recycling’s New $100,000 Waste to Energy Renovation 2
... EVRY, France, May 5 Novagali Pharma, ... the Company,s,Investigational New Drug Application (IND) to ... (Nova21027), for the treatment of glaucoma has ... Administration (FDA). Catioprost(R) is a,topical ocular proprietary ...
... Insmed Inc. (Nasdaq: INSM ), a ... from The NASDAQ Stock Market that it has regained ... requirement, and further, that it currently complies with all ... with the bid price rule, the Company was required ...
... lamps have been used to control outbreaks of measles, ... and hospitals since the 1930,s. UVGI (Ultraviolet Germicidal Irradiation) ... 1955 Mumps epidemic and helped eliminate a Varicella (Chicken ... recently, UVGI units were installed into Hong Kong hospitals ...
Cached Biology Technology:Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma 2Insmed Regains NASDAQ Compliance 2Swine Flu Fears Generate Interest in UV Disinfection Technologies...Again 2
... The Genome Sequencer 20 System revolutionizes DNA ... parallel fashion. The Genome Sequencer 20 ... Reagents and consumables for library construction, ... mapping and de novo assembly ...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds....
... Normal Human Serum-Single Donor • Human ... who are found to be negative by ... (s) (HIV-1Ag), Antibodies to Human Immunodeficiency Virus ... Nonreactive for Hepatitis B Surface Antigen (HbsAg) ...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates....
Biology Products: